Common steroid may shield liver during cancer radiation
NCT ID NCT05901519
Summary
This study is testing if a common steroid called prednisone can protect the liver from damage during radiation treatment for liver cancer. Twenty patients at high risk for liver inflammation will take prednisone for a few days before and during their radiation therapy. Researchers will measure blood markers of inflammation and liver function to see if the steroid reduces harmful side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rogel Comprehensive Cancer Center
RECRUITINGAnn Arbor, Michigan, 48187, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.